Shanghai Pharmaceuticals Holding
Integrated pharmaceutical manufacturer, developer and distributor with programs across major therapeutic areas.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 2 · Recruiting · Locally Advanced or Metastatic Breast Cancer
A Clinical Study of T3011 in Subjects With Advanced MelanomaPhase 1 · Recruiting · Advanced Melanoma
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast CancerPhase 2 · Recruiting · Locally Advanced or Metastatic Breast Cancer
Efficacy and Safety of LT3001 on Treating the Acute Ischemic StrokePhase 2 · Recruiting · Acute Ischemic Stroke
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)EARLY_Phase 1 · Recruiting · NMO Spectrum Disorder
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid TumorsEARLY_Phase 1 · Recruiting · HER2-positive Advanced Solid Tumors
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/shanghai-pharmaceuticals-holding/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.